Month: January 2019

Here are what the editors at HealthDay consider to be the most important developments in Urology for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Low-Priced Generic Drugs Most Likely to Have Shortages […]

Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Long-Term Reduction in CRC Risk After Negative […]

Here are what the editors at HealthDay consider to be the most important developments in Critical Care for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Low-Priced Generic Drugs Most Likely to Have […]

Here are what the editors at HealthDay consider to be the most important developments in Emergency Medicine for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Many EDs Do Not Have Pediatric Area, […]

Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Low-Priced Generic Drugs Most Likely to Have Shortages […]

Here are what the editors at HealthDay consider to be the most important developments in Nephrology for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Incidence of End-Stage Kidney Disease Up in Australia […]

Here are what the editors at HealthDay consider to be the most important developments in Pathology for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Novel Loci Associated With Polycystic Ovary Syndrome […]

Here are what the editors at HealthDay consider to be the most important developments in Radiology for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Catheter Ablation Tops Drug Therapy for A-Fib in […]

Here are what the editors at HealthDay consider to be the most important developments in Anesthesiology for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Low-Priced Generic Drugs Most Likely to Have Shortages […]

Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Low-Priced Generic Drugs Most Likely to Have […]

Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Catheter Ablation Tops Drug Therapy for A-Fib in […]

Here are what the editors at HealthDay consider to be the most important developments in Pain Management for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Effect Sizes Uncertain for Meds Versus Placebo […]

Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. New Guidelines Address Care for Malignant Pleural Effusions […]

Older adults with cognitive impairment admitted to skilled nursing facilities make fewer gains

Students, parents, health care providers should be aware of the availability of MenB vaccines

Population-attributable fraction varied from 3.9 percent in Montana to 6.0 percent in Texas for men

Alameda County study shows 41 percent directly transported to standalone psych emergency services

Price of alirocumab would have to decrease from original cost of $14,560 to $1,974 to be cost-effective

Rate of the primary outcome was similar for canagliflozin, glucagon-like peptide-1 agonist